Overview

Intravenous Acetaminophen in Craniotomy

Status:
Completed
Trial end date:
2016-03-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the use of intravenous Acetaminophen (OFIRMEV) as an effective adjunct therapeutic agent in patients undergoing craniotomy.
Phase:
Phase 4
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston
Collaborator:
Mallinckrodt
Treatments:
Acetaminophen